Recent Advances in Pediatric Acute Leukemia
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Pediatric Oncology".
Deadline for manuscript submissions: closed (31 July 2021) | Viewed by 43547
Special Issue Editor
Special Issue Information
Dear Colleagues,
Acute leukemia is the most frequent form of neoplastic disorders in children. Virtually incurable before the 1960s, recent overall and event-free survival rates of childhood acute lymphoblastic leukemia (ALL) have approached 90% and 80%, respectively, in high-income countries. Similar figures can be found in childhood acute myeloid leukemia (AML), at 65–75% and 55–65%, respectively. Even in well-developed regions, race, ethnicity, and socioeconomic status influence clinical outcome measures. This Special Issue is going to focus on, but will not be restricted to, recent advances in the management of childhood ALL and AML in countries with restricted resources when compared to the most developed working groups. We are going to demonstrate that application and development of innovative diagnostic methods and treatment modalities extenuate disparities in curing pediatric acute leukemia.
Dr. Csongor Kiss
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pediatric acute lymphoblastic leukemia
- pediatric acute myeloid leukemia
- survival
- management
- genetic diagnosis
- minimal residual disease
- flow cytometry
- late effects